A team of scientists from The University of Texas Health Science Center at San Antonio (UT Health San Antonio) has identified ...

The first patient with relapsed or refractory acute myeloid leukemia has been dosed with Annamycin plus Cytarabine in the ...

Syndax has a strong cash position and a significant market opportunity with Revuforj and Niktimvo. Check out my ...

One main goal of anti-cancer therapies is to kill tumor cells without affecting the surrounding normal cells. Therefore, many ...

A team of scientists from The University of Texas Health Science Center at San Antonio (UT Health San Antonio) has identified a promising new drug target for acute myeloid leukemia (AML), a deadly ...

The following is a summary of “Efficacy and safety of decitabine combined with arsenic trioxide in elderly high-risk ...

Monzr M. Al Malki, MD, discussed data for AlloHeme, a blood test used to detect risk of relapse post-transplant in patients ...

Scientists have identified a promising new drug target for acute myeloid leukemia, a deadly blood cancer with a five-year ...